AIDSWEEKLY Plus; Monday, April 30, 2007
Staff Medical Writers

The white paper addresses the current situation faced by U.S. State and Territory ADAPs and proposes a potential solution - a national enrollment system - that could assist in delivering more funding to patients through each State's program. Examples of quality assurance and disaster preparedness highlight inefficiencies in ADAP management that could be addressed through the proposed solution. In such a system, each state's individual database would be linked to the national database for easy cross referencing of data and confirmation of eligibility. The free paper titled, "Limited ADAP Funding Requires National Solution," is available at www.PHSB.com.

"ADAPs play a key role in providing medications to hundreds of thousands of Americans living with HIV/AIDS," said William E. Arnold, CEO of TII CANN and the Director of The National ADAP Working Group. "Any system that improves efficiency and ensures services reach those in need is a step in the right direction. The current lack of a national enrollment system leaves all parties involved in ADAP administration at a huge disadvantage."

"The idea of a national enrollment system grew out of our experience helping States manage their ADAP programs. It became clear that a number of problems could be solved, resulting in more resources available to those in need. If a national enrollment solution were in place, combined with coordination of benefits and the ability to enforce payer of last resort requirements, we estimate this could save between three to five percent, or between $40 - $65 million each year," said Eric Flowers, President and CEO of Public Health Service Bureau.

Keywords: HIV/AIDS, AIDS, Acquired Immunodeficiency Syndrome, HIV, Human Immunodeficiency Virus, Public Health, Virology, Public Health Service Bureau.

This article was prepared by AIDS Weekly editors from staff and other reports.

2007-04-30
AW070413

Copyright © 2007 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.